Americafirst Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$260K Buy
+1,361
New +$259K 0.35% 125
2016
Q3
Sell
-13,621
Closed -$1.79M 233
2016
Q2
$1.79M Buy
13,621
+1,045
+8% +$143K 1.16% 32
2016
Q1
$1.75M Sell
12,576
-4,900
-28% -$655K 1.09% 30
2015
Q4
$2.44M Buy
17,476
+2,764
+19% +$381K 1.48% 25
2015
Q3
$2.06M Buy
14,712
+2,170
+17% +$326K 1.21% 17
2015
Q2
$2.06M Sell
12,542
-3,450
-22% -$551K 1.11% 15
2015
Q1
$2.47M Buy
15,992
+13,680
+592% +$1.95M 1.23% 14
2014
Q4
$291K Sell
2,312
-10,915
-83% -$1.35M 0.14% 187
2014
Q3
$1.58M Buy
+13,227
New +$1.52M 0.78% 29

Other funds holding ELV

Americafirst Capital Management's ELV Position: Q3 2017 in Review

Americafirst Capital Management opened a new position in Elevance Health (ELV) in Q3 2017: 1,361 shares worth $260K. The stake represents 0.35% of the portfolio and ranks #125 among its holdings. This is a return to the name: Americafirst Capital Management previously reported a position in ELV as recently as Q2 2016.

Americafirst Capital Management first reported a position in ELV in Q3 2014 and has held it in 9 quarters since. The position peaked at $2.47M in Q1 2015. 845 funds tracked by Wall St. Rank hold ELV as of Q3 2017.

  • Americafirst Capital Management held 1,361 shares of Elevance Health worth $260K as of Q3 2017.
  • Elevance Health was a new Americafirst Capital Management position in Q3 2017.
  • Elevance Health made up 0.35% of Americafirst Capital Management's portfolio in Q3 2017, its #125 holding.
  • Americafirst Capital Management first reported a position in Elevance Health in Q3 2014 and has held it in 9 quarters since.
  • Americafirst Capital Management's Elevance Health position peaked at $2.47M in Q1 2015.
  • 845 funds tracked by Wall St. Rank held Elevance Health as of Q3 2017.

Based on Americafirst Capital Management's 13F filing for Q3 2017, filed 16 Nov 2017.